SciBac Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $287K
Latest Deal Amount
  • Investors
  • 8

SciBac General Information

Description

Developer of biotherapeutics intended to treat antibiotic-resistant diseases and fortify the microbiome. The company's technology improves beneficial microorganisms using a patented platform that uses a type of directed evolution to increase therapeutic efficacy and targets a specific disease through multiple modes of action, thereby enabling hospitals to enhance the microbiome for faster recovery and reduced risk of reinfections.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Primary Office
  • 1828 El Camino Real
  • Suite 704
  • Burlingame, CA 94010
  • United States
+1 (650) 000-0000

SciBac Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SciBac Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Grant 09-Jul-2019 $287K 00.000 Completed Generating Revenue
7. Early Stage VC 07-Jan-2019 00000 00.000 Completed Generating Revenue
6. Grant 20-Jul-2018 00.000 00000 Completed Generating Revenue
5. Early Stage VC 20-Mar-2018 00000 00000 Completed Generating Revenue
4. Grant 01-Apr-2017 00000 Completed Startup
3. Accelerator/Incubator 04-Apr-2016 Completed Startup
2. Early Stage VC 01-Apr-2016 $450K Completed Startup
1. Accelerator/Incubator 01-Jan-2016 Completed Startup
To view SciBac’s complete valuation and funding history, request access »

SciBac Executive Team (4)

Name Title Board Seat Contact Info
Jeanette Mucha Co-Founder, Chief Executive Officer, Chief Science Officer, President and Board Member
Derik Twomey Co-Founder, Chief Operating Officer & Board Member
Anthony Cann Ph.D Co-Founder, Chief Technology Officer & Board Member
To view SciBac’s complete executive team members history, request access »

SciBac Board Members (3)

Name Representing Role Since
Anthony Cann Ph.D SciBac Co-Founder, Chief Technology Officer & Board Member 000 0000
Derik Twomey SciBac Co-Founder, Chief Operating Officer & Board Member 000 0000
Jeanette Mucha SciBac Co-Founder, Chief Executive Officer, Chief Science Officer, President and Board Member 000 0000
To view SciBac’s complete board members history, request access »

SciBac Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SciBac Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
Lagomaj Capital Venture Capital Minority 000 0000 000000 0
Tillman Venture Partners Venture Capital Minority 000 0000 000000 0
CARB-X University 000 0000 000000 0
Breakout Labs Not-For-Profit Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »